Rezolute, Inc. logo

RZLTRezolute, Inc.

RZLT Stock Price, Valuation & Chart | Rezolute, Inc.

Compare

RZLT Historical price chart

RZLT Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization439.09M
PE Ratio-5.56
EPS-0.82
Trading Volume857.32K
Today's High/Low4.61/4.43
Dividend Yield0.00
52 Week High/Low11.46/1.07
Shares Outstanding96.29M
RZLT Financial Statement
RZLT Analyst ratings
RZLT Analysis & performance metrics

RZLT Company profile

Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United…

RZLT Management team

Management
Raj Agrawal M.D.
Vice President & Head of Ophthalmological Clinical Development
Michael R. Deperro
Senior Vice President & Head of Corporate Development
Chris Milks
Vice President & Head of Finance
Nevan Charles Elam J.D.CEO
Founder, Chief Executive Officer, Principal Financial Officer & Acting Chairman of the Board
Daron G. Evans M.B.A., M.S.CFO
Chief Financial Officer
Brian Kenneth Roberts M.D.
Chief Medical Officer
Robyn Sweinhart
Vice President & Head of Quality
Erin O'Boyle
Senior Vice President & Head of Clinical Operations
Total 8 executives

RZLT Frequently asked questions

What is Rezolute, Inc. (RZLT) Stock Price?

Current stock price of Rezolute, Inc. (RZLT) stock is $4.560. The stock price is +1.33% higher in the session. The intraday range can be seen from this page. Volume of Rezolute, Inc. (RZLT) stock is 857.32K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Rezolute, Inc. (RZLT) stock price going up or down today?

The stock price of Rezolute, Inc. (RZLT) can change with earnings, company news, and overall market sentiment. Rezolute, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Rezolute, Inc. stock expensive at its current price?

Whether Rezolute, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RZLT on this page is -5.56. EPS on this page is -0.82. Compare those figures with peers and growth expectations before deciding if the current Rezolute, Inc. price is justified.

How has the stock price of Rezolute, Inc. (RZLT) performed historically?

Historical performance for Rezolute, Inc. (RZLT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RZLT reacted to past earnings and market events.

Should I buy Rezolute, Inc. (RZLT) stock, at this price?

Buying Rezolute, Inc. (RZLT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.